Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
End stage kidney disease
Do you favor peritoneal dialysis over hemodialysis in patients with an LVAD who have ESKD?
Related Questions
How do you approach the management of a patient with nonoliguric ESKD, massive proteinuria, and hypoalbuminemia who is already on an ACE inhibitor?
How do you work up and manage an ESKD patient with controlled blood pressure who complains of recurrent headaches while on hemodialysis?
What degree of prolactin elevation is typically seen in patients with end stage kidney disease on hemodialysis?
Do you stop ACEi or ARB medications in patients with ESKD who are on hemodialysis and have issues with chronic hyperkalemia?
Would you continue spironolactone in a patient who has recently progressed to ESKD on HD with oliguria and was diagnosed with primary hyperaldosteronism years ago?
How do you titrate midodrine in your patients with ESKD who suffer from intradialytic hypotension?
Do you take any special considerations for a patient with ESKD who has an ileostomy/colostomy and wishes to start peritoneal dialysis?
For optimal GDMT for patients with HFrEF and co-existing ESRD, is there evidence to support the use of SGLT2 inhibitors and/or ARB/ARNI?
How would you approach the timing of hemodialysis for an ESKD patient with no urgent indications who has NSTEMI with a troponin level of 10 ng/dl, has not had dialysis in 2 days, and is planned for left heart catheterization the next day?
Are there instances when you would prescribe a phosphate binder to an ESKD patient on hemodialysis who has a phosphorus level in the target range of less than 5.5 mg/dL?
